Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Lines

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cephalalgia : an International Journal of Headache|February 13, 2009
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adultsT W Ho, X Fan, A Rodgers, et al.
Psychopharmacology|January 1, 1989
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmineG C Preston, C Ward, C R Lines, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humansC J Hawkey, L Jackson, S E Harper, et al.
Obstetrics and Gynecology|July 26, 2000
Rizatriptan in the treatment of menstrual migraineS D Silberstein, H Massiou, C Le Jeunne, et al.
Archives of Neurology|November 1, 1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study GroupW H Visser, G M Terwindt, S A Reines, et al.
Neurology|November 30, 2000
Within-patient consistency of response of rizatriptan for treating migraineC G Dahlöf, R B Lipton, K A McCarroll, et al.
Neurology|November 19, 2008
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trialJ J Sevigny, J M Ryan, C H van Dyck, et al.
Neurology|October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacyJ U Adelman, R B Lipton, M D Ferrari, et al.
Headache|September 29, 2001
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysisR B Lipton, J Pascual, P J Goadsby, et al.
Neurology|October 5, 2007
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineT W Ho, L K Mannix, X Fan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cephalalgia : an International Journal of Headache|February 13, 2009
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adultsT W Ho, X Fan, A Rodgers, et al.
Psychopharmacology|January 1, 1989
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmineG C Preston, C Ward, C R Lines, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humansC J Hawkey, L Jackson, S E Harper, et al.
Obstetrics and Gynecology|July 26, 2000
Rizatriptan in the treatment of menstrual migraineS D Silberstein, H Massiou, C Le Jeunne, et al.
Archives of Neurology|November 1, 1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study GroupW H Visser, G M Terwindt, S A Reines, et al.
Neurology|November 30, 2000
Within-patient consistency of response of rizatriptan for treating migraineC G Dahlöf, R B Lipton, K A McCarroll, et al.
Neurology|November 19, 2008
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trialJ J Sevigny, J M Ryan, C H van Dyck, et al.
Neurology|October 24, 2001
Comparison of rizatriptan and other triptans on stringent measures of efficacyJ U Adelman, R B Lipton, M D Ferrari, et al.
Headache|September 29, 2001
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysisR B Lipton, J Pascual, P J Goadsby, et al.
Neurology|October 5, 2007
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineT W Ho, L K Mannix, X Fan, et al.
Pageof 4